---
title: "Healthy Extracts Inc. (HYEX.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/HYEX.US.md"
symbol: "HYEX.US"
name: "Healthy Extracts Inc."
industry: "Personal Care Products"
---

# Healthy Extracts Inc. (HYEX.US)

| Item | Detail |
|------|--------|
| Industry | Personal Care Products |
| Location | US Market |
| Website | [www.healthyextractsinc.com](https://www.healthyextractsinc.com) |

## Company Profile

Healthy Extracts Inc., through its subsidiaries, engages in the acquiring, developing, patenting, marketing, and distribution of plant-based nutraceuticals in the United States. It operates through two segments: Corporate and Health Supplements. The company’s proprietary and patented products target...

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-25T04:30:13.000Z

**Overall: C (0.45)**

**Industry**: Personal Care Products

| Metric | Value |
|--------|-------|
| Industry Ranking | 28 / 58 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 19.20% |  |
| Net Profit YoY | -52.01% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 1.65 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 39.65M |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 3.59M |  |


**Multi Score**: C

#### Profit Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -9.44% | D |
| Profit Margin | -32.71% | E |
| Gross Margin | 48.72% | B |

#### Growth Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 19.20% | B |
| Net Profit YoY | -52.01% | D |
| Total Assets YoY | 961.30% | A |
| Net Assets YoY | 2896.60% | A |

#### Cash Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | -305.70% | D |
| OCF YoY | 19.20% | B |

#### Operating Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.25 | D |

#### Debt Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 8.13% | A |


```chart-data:radar
{
  "title": "Longbridge Financial Score - Healthy Extracts Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "-9.44%",
          "rating": "D"
        },
        {
          "name": "Profit Margin",
          "value": "-32.71%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "48.72%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "B",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "19.20%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "-52.01%",
          "rating": "D"
        },
        {
          "name": "Total Assets YoY",
          "value": "961.30%",
          "rating": "A"
        },
        {
          "name": "Net Assets YoY",
          "value": "2896.60%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "C",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "-305.70%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "19.20%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "D",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.25",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "A",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "8.13%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | Niagen Bioscience (US.NAGE) | A | A | A | B | B | A |
| 02 | L'Oréal S.A. (US.LRLCY) | A | B | B | C | B | B |
| 03 | Beiersdorf (US.BDRFY) | B | C | B | B | B | B |
| 04 | Kao Corporation (US.KAOOY) | B | C | A | C | B | B |
| 05 | ELF Beauty (US.ELF) | B | B | B | C | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -33.77 | 44/56 | - | - | - |
| PB | 1.65 | 19/56 | 99.19 | 32.49 | 1.40 |
| PS (TTM) | 11.05 | 44/56 | 9.40 | 6.42 | 1.86 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2025-11-06T05:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 0 | 0% |
| Overweight | 0 | 0% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 2.35 |
| Highest Target | 5.00 |
| Lowest Target | 5.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/HYEX.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/HYEX.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/HYEX.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.